Funding Details
- Awarder
- Inbox
- Date Award
- March 25, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Founding Year
- 2019
- Traction
- Character has collected extensive AMD patient data to inform its clinical trial design and patient selection.
- Founders
- Cheng Zhang
- Company Description
- Character Biosciences is a biotechnology startup developing treatments for vision loss, specifically targeting the 'dry' form of age-related macular degeneration (AMD). The company is advancing two drug candidates, CTX114 and CTX203, into clinical testing to address geographic atrophy and stabilize protein expression in retinal cells.
- Market
- Vision loss treatments
- Location
-
USA
- Coinvestors
- aMoon, Luma Group, Bausch + Lomb, Jefferson Life Sciences
Links